EVOLOCUMAB for Coronary artery disease: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 1,266 adverse event reports in the FDA FAERS database where EVOLOCUMAB was used for Coronary artery disease.
Most Reported Side Effects for EVOLOCUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Device difficult to use | 31,807 | 21.3% | 11 | 538 |
| Drug dose omission by device | 23,957 | 16.0% | 7 | 327 |
| Wrong technique in product usage process | 21,664 | 14.5% | 4 | 285 |
| Accidental exposure to product | 16,160 | 10.8% | 3 | 154 |
| Injection site pain | 9,988 | 6.7% | 3 | 154 |
| Product storage error | 6,606 | 4.4% | 2 | 88 |
| Back pain | 5,254 | 3.5% | 14 | 201 |
| Myalgia | 5,061 | 3.4% | 15 | 177 |
| Drug dose omission | 4,914 | 3.3% | 1 | 87 |
| Injection site bruising | 4,409 | 3.0% | 1 | 83 |
| Device use error | 4,002 | 2.7% | 0 | 76 |
| Injection site haemorrhage | 3,720 | 2.5% | 1 | 50 |
| Arthralgia | 3,692 | 2.5% | 10 | 175 |
| Off label use | 3,558 | 2.4% | 23 | 153 |
| Fatigue | 3,506 | 2.3% | 7 | 165 |
Other Indications for EVOLOCUMAB
Product used for unknown indication (60,696)
Blood cholesterol increased (29,401)
Hypercholesterolaemia (23,505)
Blood cholesterol abnormal (13,116)
Hyperlipidaemia (10,208)
Type iia hyperlipidaemia (5,556)
Low density lipoprotein increased (2,740)
Arteriosclerosis (2,094)
Type v hyperlipidaemia (1,816)
Dyslipidaemia (1,056)
Other Drugs Used for Coronary artery disease
ASPIRIN (2,758)
CLOPIDOGREL BISULFATE (1,584)
ATORVASTATIN (891)
RIVAROXABAN (847)
DILTIAZEM (664)
ROSUVASTATIN (600)
TICAGRELOR (520)
QUINAPRIL (511)
AMLODIPINE (486)
NITROGLYCERIN (421)